Brief: Pmv Pharmaceuticals To Present Updated Phase 1 Data On Pc14586 At The 2023 Aacr-Nci-Eortc International Conference On Molecular Targets And Cancer Therapeutics
20/09/2023 22:15
PMV Pharmaceuticals Inc PMVP.O :
* PMV PHARMACEUTICALS TO PRESENT UPDATED PHASE 1 DATA ON
PC14586
AT THE 2023 AACR-NCI-EORTC INTERNATIONAL CONFERENCE ON MOLECULAR
TARGETS AND CANCER THERAPEUTICS
Source text for Eikon: ID:nGNXFhqpL
Further company coverage: PMVP.O
Recent news on Pmv Pharmaceuticals
See all newsAustralia's Premier Investments jumps as Citi backs in-line earnings
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple
U.S. STOCKS ON THE MOVE-GoPro, TXNM Energy, Emergent BioSolutions
U.S. STOCKS ON THE MOVE-Fervo Energy, Myriad Genetics, Emergent BioSolutions
U.S. STOCKS ON THE MOVE-Robinhood Markets, Park Hotels & Resorts, Capricor Therapeutics